AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
+10.2%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
Cap. Flow
+$35.1M
Cap. Flow %
13.49%
Top 10 Hldgs %
49.44%
Holding
80
New
15
Increased
23
Reduced
13
Closed
6

Top Buys

1
MRK icon
Merck
MRK
$12.8M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$8.05M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
$5.57M
4
BBIO icon
BridgeBio Pharma
BBIO
$5.31M
5
CYTK icon
Cytokinetics
CYTK
$4.71M

Top Sells

1
MORF
Morphic Holding, Inc. Common Stock
MORF
$5.46M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$5.35M
3
ESTA icon
Establishment Labs
ESTA
$5.25M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
$5.05M
5
NARI
Inari Medical, Inc. Common Stock
NARI
$4.32M

Sector Composition

1 Healthcare 92.55%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LNTH icon
26
Lantheus
LNTH
$3.73B
$2.5M 0.82% 30,244 -30,386 -50% -$2.51M
BMRN icon
27
BioMarin Pharmaceuticals
BMRN
$11.2B
$2.43M 0.8% 25,000 -55,000 -69% -$5.35M
PCVX icon
28
Vaxcyte
PCVX
$4B
$2.33M 0.77% 62,223 +2,223 +4% +$83.3K
APLS icon
29
Apellis Pharmaceuticals
APLS
$3.48B
$2.31M 0.76% +35,000 New +$2.31M
MIRM icon
30
Mirum Pharmaceuticals
MIRM
$3.71B
$2.28M 0.75% 95,000 +55,000 +138% +$1.32M
KRTX
31
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.27M 0.75% +12,500 New +$2.27M
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.18M 0.72% 20,000 -25,000 -56% -$2.73M
ALPN
33
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$1.91M 0.63% 247,891 – –
CLDX icon
34
Celldex Therapeutics
CLDX
$1.47B
$1.8M 0.59% 50,000 -60,000 -55% -$2.16M
KPTI icon
35
Karyopharm Therapeutics
KPTI
$61.7M
$1.79M 0.59% 460,979 -200,285 -30% -$779K
KALV icon
36
KalVista Pharmaceuticals
KALV
$678M
$1.64M 0.54% 208,292 +20,000 +11% +$157K
VINC
37
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$1.55M 0.51% 1,492,771 – –
COGT icon
38
Cogent Biosciences
COGT
$1.69B
$1.54M 0.51% 143,064 -50,000 -26% -$540K
NRIX icon
39
Nurix Therapeutics
NRIX
$714M
$1.33M 0.44% 150,000 +70,000 +88% +$622K
LIAN
40
DELISTED
LianBio American Depositary Shares
LIAN
$1.27M 0.42% 650,000 – –
NARI
41
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.23M 0.41% 20,000 -70,000 -78% -$4.32M
ADCT icon
42
ADC Therapeutics
ADCT
$345M
$1.17M 0.39% +600,000 New +$1.17M
PNT
43
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$1.09M 0.36% 149,586 -153,632 -51% -$1.12M
MLYS icon
44
Mineralys Therapeutics
MLYS
$1.03B
$979K 0.32% +62,500 New +$979K
THRX
45
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$872K 0.29% +98,221 New +$872K
BCAB icon
46
BioAtla
BCAB
$26.7M
$871K 0.29% 325,000 +175,000 +117% +$469K
JSPR icon
47
Jasper Therapeutics
JSPR
$45.5M
$863K 0.28% +476,948 New +$863K
FHTX icon
48
Foghorn Therapeutics
FHTX
$286M
$848K 0.28% 136,771 +26,780 +24% +$166K
MIST icon
49
Milestone Pharmaceuticals
MIST
$156M
$786K 0.26% 199,382 +99,382 +99% +$392K
ROIV icon
50
Roivant Sciences
ROIV
$8.15B
$738K 0.24% +100,000 New +$738K
1
2
3 4